Hint mode is switched on Switch off

LABU - Direxion Daily S&P Biotech Bull 3X Shares (USD) (US25460G1206)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all

Leveraged

 
(%)
US25460G1206
LABU ISIN
Exchange Traded Funds (ETF)
Type of fund
Direxion Funds
Provider
-
NAV per Share
28/05/2015
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
LABU
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
The S&P Biotechnology Select Industry Index
Benchmark
0.93 %
Total Cost Ratio
579.24 mln USD
Fund NAV | 17/07/2026
579.24 mln USD
Share Class NAV | 17/07/2026
No
UCITS
20 / 1 (02/12/2023)
Split

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 17/07/2026, NYSE Arca

  • YTD
    1.98 %
  • 1M
    -23.81 %
  • 3M
    -3.65 %
  • 6M
    17.4 %
  • 1Y
    219.99 %
  • 3Y
    27.39 %
  • 5Y
    -86.86 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (LABU)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

LABU profile

The Direxion Daily S&P Biotech Bull 3X Shares (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Direxion Funds fund’s base currency is USD and the share class was registered 28.05.2015 with unique ISIN - US25460G1206. Main exchange is NYSE Arca and ticker symbol is LABU. The total expense ratio is 0.93%. The Direxion Daily S&P Biotech Bull 3X Shares (USD) pays dividends 4 time(s) per year.

Structure LABU on 20/07/2026

Download structure in Excel
Paper Value
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 78.43%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 53.64%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 48.85%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 32.88%
GOLDMAN FINL SQ TRSRY INST 506 20.17%
DREYFUS GOVT CASH MAN INS 13.81%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 12.42%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 11.98%
GOLDMAN SACHS FIN GOV 465 INSTITUT 7.32%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 4.44%
APOGEE THERAPEUTICS INC 0.9%
KYMERA THERAPEUTICS INC 0.82%
ORUKA THERAPEUTICS INC 0.81%
ERASCA INC 0.8%
TWIST BIOSCIENCE CORP 0.77%
DIANTHUS THERAPEUTICS INC 0.77%
MODERNA INC 0.75%
VIKING THERAPEUTICS INC 0.74%
SPYRE THERAPEUTICS INC 0.74%
PROTAGONIST THERAPEUTICS INC 0.74%
CG ONCOLOGY INC 0.73%
PRAXIS PRECISION MEDICINES I 0.73%
REVOLUTION MEDICINES INC 0.72%
MIRUM PHARMACEUTICALS INC 0.7%
RELAY THERAPEUTICS INC 0.7%
NATERA INC 0.7%
COGENT BIOSCIENCES INC 0.69%
RHYTHM PHARMACEUTICALS INC 0.69%
VAXCYTE INC 0.69%
ROIVANT SCIENCES LTD 0.68%
TRAVERE THERAPEUTICS INC 0.67%
BRIDGEBIO PHARMA INC 0.67%
ALKERMES PLC 0.67%
SCHOLAR ROCK HOLDING CORP 0.67%
CYTOKINETICS INC 0.66%
INSMED INC 0.66%
TG THERAPEUTICS INC 0.65%
MADRIGAL PHARMACEUTICALS INC 0.65%
SELLAS LIFE SCIENCES GROUP I 0.64%
KRYSTAL BIOTECH INC 0.63%
ABBVIE INC 0.63%
REGENERON PHARMACEUTICALS 0.63%
VERTEX PHARMACEUTICALS INC 0.62%
INCYTE CORP 0.62%
GILEAD SCIENCES INC 0.61%
HALOZYME THERAPEUTICS INC 0.61%
AMGEN INC 0.6%
ULTRAGENYX PHARMACEUTICAL IN 0.6%
PTC THERAPEUTICS INC 0.6%
EXELIXIS INC 0.59%
NEUROCRINE BIOSCIENCES INC 0.59%
BIOMARIN PHARMACEUTICAL INC 0.59%
BIOGEN INC 0.59%
ARROWHEAD PHARMACEUTICALS IN 0.58%
IMMUNOVANT INC 0.58%
GRAIL INC 0.58%
SUMMIT THERAPEUTICS INC 0.57%
VERA THERAPEUTICS INC 0.57%
ACADIA PHARMACEUTICALS INC 0.57%
CELCUITY INC 0.56%
DYNE THERAPEUTICS INC 0.55%
UNITED THERAPEUTICS CORP 0.55%
UNIQURE NV 0.54%
CRISPR THERAPEUTICS AG 0.54%
IMMUNITYBIO INC 0.54%
BEAM THERAPEUTICS INC 0.52%
ALNYLAM PHARMACEUTICALS INC 0.51%
BIOCRYST PHARMACEUTICALS INC 0.5%
VERACYTE INC 0.49%
IDEAYA BIOSCIENCES INC 0.47%
ARCUTIS BIOTHERAPEUTICS INC 0.46%
TANGO THERAPEUTICS INC 0.46%
DENALI THERAPEUTICS INC 0.45%
SYNDAX PHARMACEUTICALS INC 0.45%
AGIOS PHARMACEUTICALS INC 0.44%
SAREPTA THERAPEUTICS INC 0.43%
MINERALYS THERAPEUTICS INC 0.43%
IONIS PHARMACEUTICALS INC 0.41%
DISC MEDICINE INC 0.41%
IOVANCE BIOTHERAPEUTICS INC 0.41%
CELLDEX THERAPEUTICS INC 0.4%
ARCUS BIOSCIENCES INC 0.4%
VIRIDIAN THERAPEUTICS INC 0.39%
ADMA BIOLOGICS INC 0.38%
IMMUNOME INC 0.37%
INTELLIA THERAPEUTICS INC 0.37%
RECURSION PHARMACEUTICALS-A 0.36%
PALVELLA THERAPEUTICS INC 0.36%
KODIAK SCIENCES INC 0.36%
NOVAVAX INC 0.35%
BIOHAVEN LTD 0.33%
NURIX THERAPEUTICS INC 0.32%
VERICEL CORP 0.31%
MONTE ROSA THERAPEUTICS INC 0.29%
VIR BIOTECHNOLOGY INC 0.26%
STOKE THERAPEUTICS INC 0.26%
ANAPTYSBIO INC 0.26%
CAREDX INC 0.25%
TYRA BIOSCIENCES INC 0.25%
CORVUS PHARMACEUTICALS INC 0.24%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.